Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| Sofosbuvir | Sofosbuvir. CAS No. 1190307-88-0. Product ID: 8-04873. Molecular formula: C22H29FN3O9P. Mole weight: 529.45. Properties: ex Melaleuca alternifolia. |  |
| Sofosbuvir | Sofosbuvir (GS-7977) is an HCV RNA replication inhibitor with an EC 50 of 92 nM [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: GS-7977; PSI-7977. CAS No. 1190307-88-0. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg; 500 mg; 1 g. Product ID: HY-15005. |  |
| Sofosbuvir | Sofosbuvir (GS-7977) is an HCV RNA replication inhibitor with an EC50 of 92 nM. Uses: Designed for use in research and industrial production. Additional or Alternative Names: SOFOSBUVIR;PSI-7977;SOVALDI;1190307-88-0;GS-7977;PSI 7977;UNII-WJ6CA3ZU8B;GS7977;WJ6CA3ZU8B;CHEBI:85083;Sofosbuvir [USAN:INN];C22H29FN3O9P;Hepcinat;Hepcvir;Resof;SoviHep;HSDB 8226;PSI7977;Sovaldi (TN);Sofosbuvir (PSI-7977, GS-7977);Sofosbuvir (JAN/USAN);Sofosbuvir(PSI-7977);2-((5-(2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-ylmethoxy)phenoxyphosphorylamino. Product Category: Inhibitors. Appearance: Solid. CAS No. 1190307-88-0. Molecular formula: C22H29FN3O9P. Mole weight: 529.5g/mol. Purity: 0.9993. IUPACName: propan-2-yl (2S)-2-[[[(2R,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyloxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate. Canonical SMILES: CC(C)OC(=O)C(C)NP(=O)(OCC1C(C(C(O1)N2C=CC(=O)NC2=O)(C)F)O)OC3=CC=CC=C3. Product ID: ACM1190307880. Alfa Chemistry ISO 9001:2015 Certified. |  |
| Sofosbuvir | Sofosbuvir is a prodrug that is metabolized to the active antiviral agent 2'-deoxy-2'-α-fluoro-β-C-methyluridine-5'-monophosphate and is currently being investigated in phase 3 clinical trials for the treatment of hepatitis C. Studies have profiled sofosbuvir as a nucleotide inhibitor of hepatitis C virus, exerting selective inhibitory effects towards HCV NS5B polymerase. Uses: Antiviral agents. Synonyms: PSI-7977; PSI 7977; PSI7977; GS7977; GS-7977; GS 7977; Sovaldi; N-[[P(S),2'R]-2'-deoxy-2'-fluoro-2'-methyl-P-phenyl-5'-uridylyl]-L-alanine, 1-methylethyl ester; Hepcinat; Hepcvir; Resof; SoviHep. Grades: >98%. CAS No. 1190307-88-0. Molecular formula: C22H29FN3O9P. Mole weight: 529.45. |  |
| Sofosbuvir 3',5'-Bis-(S)-phosphate | Sofosbuvir 3',5'-Bis-(S)-phosphate, an impurity of PSI-7977, which is a prodrug that is metabolized to the active antiviral agent 2'-deoxy-2'-α-fluoro-β-C-methyluridine-5'-monophosphate and is currently being investigated in phase 3 clinical trials for the treatment of hepatitis C. Studies have profiled PSI-7977 as a nucleotide inhibitor of hepatitis C virus, exerting selective inhibitory effects towards HCV NS5B polymerase. Synonyms: (2S)-Isopropyl 2- ( ( ( ( (2R, 3R, 4R, 5R)-5- (2, 4-Dioxo-3, 4-dihydropyrimidin-1 (2H)-yl)-4-fluoro-2- ( ( ( (R)- ( ( (S)-1-isopropoxy-1-oxopropan-2-yl)amino) (phenoxy)phosphoryl)oxy)methyl)-4-methyltetrahydrofuran-3-yl)oxy) (phenoxy)phosphoryl)amino)propanoate. Grades: 98.77%. CAS No. 1337482-17-3. Molecular formula: C34H45FN4O13P2. Mole weight: 798.69. | |
| Sofosbuvir α-Isomer | As a derivative compound of Sofosbuvir, Sofosbuvir α-Isomer is a prodrug that is metabolized to the active antiviral agent 2'-deoxy-2'-α-fluoro-β-C-methyluridine-5'-monophosphate and is currently being investigated in phase 3 clinical trials for the treatment of hepatitis C. Studies have shown PSI-7977 as a nucleotide inhibitor of hepatitis C virus, exerting selective inhibitory effects towards HCV NS5B polymerase. Synonyms: (S)-Isopropyl 2- ( ( (S)- ( ( (2R, 3R, 4R, 5S)-5- (2, 4-dioxo-3, 4-dihydropyrimidin-1 (2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy) (phenoxy)phosphoryl)amino)propanoate. Molecular formula: C22H29FN3O9P. Mole weight: 529.45. | |
| Sofosbuvir Carboxylic Acid | As an impurity of Sofosbuvir, Sofosbuvir Carboxylic Acid is a prodrug that is metabolized to the active antiviral agent 2'-deoxy-2'-α-fluoro-β-C-methyluridine-5'-monophosphate and is currently being investigated in phase 3 clinical trials for the treatment of hepatitis C. Studies have profiled Sofosbuvir as a nucleotide inhibitor of hepatitis C virus, exerting selective inhibitory effects towards HCV NS5B polymerase. Synonyms: (S)-2- ( ( (S)- ( ( (2R, 3R, 4R, 5R)-5- (2, 4-Dioxo-3, 4-dihydropyrimidin-1 (2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy) (phenoxy)phosphoryl)amino)propanoic Acid. Molecular formula: C19H23FN3O9P. Mole weight: 487.37. | |
| Sofosbuvir Impurity 1 | An impurity of Sofosbuvir. Sofosbuvir is a NS5B inhibtor used for the treatment of hepatitis C. It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir or daclatasvir. Synonyms: (2R,3R,4S,5R)-5-(4-Benzamido-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4-fluoro-4-methyltetrahydrofuran-3-yl Benzoate; N4,3',5'-Tribenzoyl,2'-deoxy-2'β-fluoro-2'C-α-methyl Cytidine. Grades: > 95%. Molecular formula: C31H26FN3O7. Mole weight: 571.55. | |
| Sofosbuvir Impurity 10 | An impurity of Sofosbuvir. Sofosbuvir is a NS5B inhibtor used for the treatment of hepatitis C. It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir or daclatasvir. Synonyms: Uridine, 2'-deoxy-2'-methylene-, 3',?5'-dibenzoate. Grades: > 95%. CAS No. 1910099-17-0. Molecular formula: C24H20N2O7. Mole weight: 448.42. | |
| Sofosbuvir Impurity 11 | An impurity of Sofosbuvir. Sofosbuvir is a NS5B inhibtor used for the treatment of hepatitis C. It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir or daclatasvir. Synonyms: 2'-epi-Sofosbuvir Desphosphate. Grades: > 95%. Molecular formula: C10H13FN2O5. Mole weight: 260.22. | |
| Sofosbuvir Impurity 12 | An impurity of Sofosbuvir. Sofosbuvir is a NS5B inhibtor used for the treatment of hepatitis C. It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir or daclatasvir. Synonyms: 2'-c-methyl arabino-uridine; 1-(2-C-Methyl-β-D-arabinofuranosyl)-2,4(1H,3H)-pyrimidinedione; 1-((2R,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione. Grades: > 95%. CAS No. 114262-49-6. Molecular formula: C10H14N2O6. Mole weight: 258.23. | |
| Sofosbuvir Impurity 13 | An impurity of Sofosbuvir. Sofosbuvir is a NS5B inhibtor used for the treatment of hepatitis C. It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir or daclatasvir. Synonyms: 2'-Methylene-2'-deoxyuridine; 2'-Methylidene-2'-deoxyuridine; 2'-Deoxy-2'-methyleneuridine. Grades: > 95%. CAS No. 119410-95-6. Molecular formula: C10H12N2O5. Mole weight: 240.22. | |
| Sofosbuvir Impurity 14 | An impurity of Sofosbuvir. Sofosbuvir is a NS5B inhibtor used for the treatment of hepatitis C. It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir or daclatasvir. Grades: > 95%. Molecular formula: C22H29FN3O9P. Mole weight: 529.46. | |
| Sofosbuvir Impurity 15 | An impurity of Sofosbuvir. Sofosbuvir is a NS5B inhibtor used for the treatment of hepatitis C. It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir or daclatasvir. Synonyms: 2'-Defluro-2'-hydroxy 2'-epi-Sofosbuvir. Grades: > 95%. Molecular formula: C22H30N3O10P. Mole weight: 527.46. | |
| Sofosbuvir Impurity 15 | Sofosbuvir Impurity 15. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1334513-02-8. Molecular formula: C18H17F5NO5P. Mole weight: 453.3. Catalog: APB1334513028. |  |
| Sofosbuvir Impurity 16 | An impurity of Sofosbuvir. Sofosbuvir is a NS5B inhibtor used for the treatment of hepatitis C. It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir or daclatasvir. Synonyms: 2'-Defluro-2'-methylene Sofosbuvir. Grades: > 95%. Molecular formula: C22H28N3O9P. Mole weight: 509.45. | |
| Sofosbuvir Impurity 17 | An impurity of Sofosbuvir. Sofosbuvir is a NS5B inhibtor used for the treatment of hepatitis C. It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir or daclatasvir. Grades: > 95%. Molecular formula: C34H45FN4O13P2. Mole weight: 798.7. | |
| Sofosbuvir Impurity 2 | An impurity of Sofosbuvir. Sofosbuvir is a NS5B inhibtor used for the treatment of hepatitis C. It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir or daclatasvir. Synonyms: Benzamide, N-[1-(3,5-di-O-benzoyl-2-C-methyl-beta-D-arabinofuranosyl)-1,2-dihydro-2-oxo-4-pyrimidinyl]-. Grades: > 95%. CAS No. 863329-62-8. Molecular formula: C31H27N3O8. Mole weight: 569.56. | |
| Sofosbuvir Impurity 20 | An impurity of Sofosbuvir. Sofosbuvir is a NS5B inhibtor used for the treatment of hepatitis C. It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir or daclatasvir. Synonyms: (2S)-Isopropyl 2- ( ( ( ( (2R, 3R, 4R, 5R) -5- (2, 4-Dioxo-3, 4-dihydropyrimidin-1 (2H) -yl) -4-fluoro-2- (hydroxymethyl) -4-methyltetrahydrofuran-3-yl) oxy) (phenoxy) phosphoryl) amino) propanoate; Sofosbuvir 5'-Desphosphate 3'-O-[(S)-Phosphate]. Grades: > 95%. CAS No. 1337482-15-1. Molecular formula: C22H29FN3O9P. Mole weight: 529.46. | |
| Sofosbuvir Impurity 21 | An impurity of Sofosbuvir. Sofosbuvir is a NS5B inhibtor used for the treatment of hepatitis C. It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir or daclatasvir. Synonyms: Chloro (R)-Phosphoryl Sofosbuvir. Grades: > 95%. CAS No. 1496552-50-1. Molecular formula: C22H29ClN3O9P. Mole weight: 545.92. | |
| Sofosbuvir Impurity 22 (GS-491241) | An impurity of Sofosbuvir. Sofosbuvir is a NS5B inhibtor used for the treatment of hepatitis C. It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir or daclatasvir. Grades: > 95%. Molecular formula: C22H29FN3O9P. Mole weight: 529.46. | |
| Sofosbuvir Impurity 23 | An impurity of Sofosbuvir. Sofosbuvir is a NS5B inhibtor used for the treatment of hepatitis C. It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir or daclatasvir. Synonyms: α-Sofosbuvir Desphosphate. Grades: 98%. CAS No. 2041584-99-8. Molecular formula: C10H13FN2O5. Mole weight: 260.22. | |
| Sofosbuvir Impurity 24 | An impurity of Sofosbuvir. Sofosbuvir is a NS5B inhibtor used for the treatment of hepatitis C. It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir or daclatasvir. Grades: > 95%. Molecular formula: C10H13FN2O5. Mole weight: 260.22. | |
| Sofosbuvir Impurity 25 | An impurity of Sofosbuvir. Sofosbuvir is a NS5B inhibtor used for the treatment of hepatitis C. It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir or daclatasvir. Grades: > 95%. Molecular formula: C10H13FN2O5. Mole weight: 260.22. | |
| Sofosbuvir Impurity 25 | Sofosbuvir Impurity 25. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1015073-43-4. Molecular formula: C10H14FN2O8P. Mole weight: 340.2. Catalog: APB1015073434. | |
| Sofosbuvir Impurity 26 | An impurity of Sofosbuvir. Sofosbuvir is a NS5B inhibtor used for the treatment of hepatitis C. It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir or daclatasvir. Grades: > 95%. Molecular formula: C10H13FN2O5. Mole weight: 260.22. | |
| Sofosbuvir Impurity 26 | Sofosbuvir Impurity 26. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1859162-80-3. Molecular formula: C16H18FN2O8P. Mole weight: 416.3. Catalog: APB1859162803. | |
| Sofosbuvir Impurity 27 | An impurity of Sofosbuvir. Sofosbuvir is a NS5B inhibtor used for the treatment of hepatitis C. It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir or daclatasvir. Grades: > 95%. Molecular formula: C10H13FN2O5. Mole weight: 260.22. | |
| Sofosbuvir Impurity 28 | An impurity of Sofosbuvir. Sofosbuvir is a NS5B inhibtor used for the treatment of hepatitis C. It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir or daclatasvir. Grades: > 95%. Molecular formula: C10H13FN2O5. Mole weight: 260.22. | |
| Sofosbuvir Impurity 29 | An impurity of Sofosbuvir. Sofosbuvir is a NS5B inhibtor used for the treatment of hepatitis C. It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir or daclatasvir. Synonyms: ent-Sofosbuvir Desphosphate. Grades: 98%. CAS No. 1946820-96-7. Molecular formula: C10H13FN2O5. Mole weight: 260.22. | |
| Sofosbuvir Impurity 3 | An impurity of Sofosbuvir. Sofosbuvir is a NS5B inhibtor used for the treatment of hepatitis C. It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir or daclatasvir. Grades: > 95%. Molecular formula: C38H31N3O9. Mole weight: 673.69. | |
| Sofosbuvir Impurity 31 | PSI-7409, the active 5'-triphosphate metabolite of PSI-7851, is a potent inhibitor of the HCV NS5B RNA dependent RNA polymerase. Synonyms: PSI-7409; PSI 7409; PSI7409; [[(2R,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyloxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate. Grades: > 95%. CAS No. 1015073-42-3. Molecular formula: C10H16FN2O14P3. Mole weight: 500.16. | |
| Sofosbuvir Impurity 32 | An impurity of Sofosbuvir. Sofosbuvir is a NS5B inhibtor used for the treatment of hepatitis C. It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir or daclatasvir. Synonyms: D-erythro-Pentonic acid, 2-deoxy-2-fluoro-2-methyl-, γ-lactone, 3,?5-dibenzoate, (2S)?-. Grades: > 95%. CAS No. 1157884-58-6. Molecular formula: C20H17FO6. Mole weight: 372.34. | |
| Sofosbuvir Impurity 33 | An impurity of Sofosbuvir. Sofosbuvir is a NS5B inhibtor used for the treatment of hepatitis C. It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir or daclatasvir. Synonyms: D-erythro-Pentonic acid, 2-chloro-2-deoxy-2-methyl-, γ-lactone, 3,?5-dibenzoate, (2R)?-. Grades: > 95%. CAS No. 1496551-65-5. Molecular formula: C20H17ClO6. Mole weight: 388.8. | |
| Sofosbuvir Impurity 34 (GS-606965) | An impurity of Sofosbuvir. Sofosbuvir is a NS5B inhibtor used for the treatment of hepatitis C. It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir or daclatasvir. Synonyms: 5'-Uridylic acid, 2'-deoxy-2'-fluoro-2'-methyl-, (2'R)?-; (2'R)-2'-Deoxy-2'-fluoro-2'-methyl-5'-uridylic acid; PSI 7411. Grades: > 95%. CAS No. 1015073-43-4. Molecular formula: C10H14FN2O8P. Mole weight: 340.2. | |
| Sofosbuvir Impurity 35 | An impurity of Sofosbuvir. Sofosbuvir is a NS5B inhibtor used for the treatment of hepatitis C. It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir or daclatasvir. Synonyms: (2'R)-2'-Chloro-2'-deoxy-2'-methyl-uridine; Chloro Sofosbuvir Desphosphate. Grades: > 95%. CAS No. 1496551-72-4. Molecular formula: C10H13ClN2O5. Mole weight: 276.68. | |
| Sofosbuvir Impurity 35 | Sofosbuvir Impurity 35. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1233335-82-4. Molecular formula: C16H25FN3O9P. Mole weight: 453.36. Catalog: APB1233335824. | |
| Sofosbuvir Impurity 36 | An impurity of Sofosbuvir. Sofosbuvir is a NS5B inhibtor used for the treatment of hepatitis C. It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir or daclatasvir. Grades: > 95%. Molecular formula: C10H15FN2O11P2. Mole weight: 420.18. | |
| Sofosbuvir Impurity 37 ( Sofosbuvir Isomer) | An impurity of Sofosbuvir. Sofosbuvir is a NS5B inhibtor used for the treatment of hepatitis C. It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir or daclatasvir. Grades: > 95%. Molecular formula: C22H29FN3O9P. Mole weight: 529.46. | |
| Sofosbuvir Impurity 38 | An impurity of Sofosbuvir. Sofosbuvir is a NS5B inhibtor used for the treatment of hepatitis C. It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir or daclatasvir. Grades: > 95%. Molecular formula: C22H29FN3O9P. Mole weight: 529.46. | |
| Sofosbuvir Impurity 39 | An impurity of Sofosbuvir. Sofosbuvir is a NS5B inhibtor used for the treatment of hepatitis C. It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir or daclatasvir. Synonyms: Benzamide, N-[1-[(2R)?-3,?5-di-O-benzoyl-2-deoxy-2-fluoro-2-methyl-α-D-erythro-pentofuranosyl]?-1,?2-dihydro-2-oxo-4-pyrimidinyl]?-; N-[1-[(2R)-3,5-Di-O-benzoyl-2-deoxy-2-fluoro-2-methyl-α-D-erythro-pentofuranosyl]-1,2-dihydro-2-oxo-4-pyrimidinyl]benzamide. Grades: 98%. CAS No. 874638-94-5. Molecular formula: C31H26FN3O7. Mole weight: 571.55. | |
| Sofosbuvir Impurity 4 | An impurity of Sofosbuvir. Sofosbuvir is a NS5B inhibtor used for the treatment of hepatitis C. It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir or daclatasvir. Synonyms: N-Benzoyl-2'-deoxy-2'-methylenecytidine 3',5'-Dibenzoate; N4,3',5'-Tribenzoyl,2'-deoxy-2'-methylene Cytidine. Grades: > 95%. CAS No. 863329-63-9. Molecular formula: C31H25N3O7. Mole weight: 551.56. | |
| Sofosbuvir Impurity 40 | An impurity of Sofosbuvir. Sofosbuvir is a NS5B inhibtor used for the treatment of hepatitis C. It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir or daclatasvir. Synonyms: Des-alanyl Sofosbuvir. Grades: > 95%. Molecular formula: C16H18FN2O8P. Mole weight: 416.29. | |
| Sofosbuvir Impurity 41 | An impurity of Sofosbuvir. Sofosbuvir is a NS5B inhibtor used for the treatment of hepatitis C. It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir or daclatasvir. Synonyms: N-[(2'R)-2'-Deoxy-2'-fluoro-2'-methyl-5'-uridylyl]-1-(1-methylethyl) Ester L-Alanine; O-Desphenyl Sofosbuvir. Grades: > 95%. CAS No. 1233335-82-4. Molecular formula: C16H25FN3O9P. Mole weight: 453.36. | |
| Sofosbuvir Impurity 42 | An impurity of Sofosbuvir. Sofosbuvir is a NS5B inhibtor used for the treatment of hepatitis C. It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir or daclatasvir. Grades: > 95%. Molecular formula: C16H25FN3O9P. Mole weight: 453.36. | |
| Sofosbuvir Impurity 43 | An impurity of Sofosbuvir. Sofosbuvir is a NS5B inhibtor used for the treatment of hepatitis C. It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir or daclatasvir. Synonyms: N-(Hydroxyphenoxyphosphinyl)-L-alanine 1-Methylethyl Ester Sodium Salt; (2S)-Isopropyl 2- ( (Hydroxy (phenoxy)phosphoryl)amino)propanoate Sodium Salt; Isopropyl N-(Hydroxyphenoxyphosphinyl)alaninate Sodium Salt. Grades: > 95%. Molecular formula: C12H17NO5P. Na. Mole weight: 286.25 22.99. | |
| Sofosbuvir Impurity 5 | An impurity of Sofosbuvir. Sofosbuvir is a NS5B inhibtor used for the treatment of hepatitis C. It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir or daclatasvir. Grades: > 95%. Molecular formula: C24H22FN3O6. Mole weight: 467.46. | |
| Sofosbuvir Impurity 6 | An impurity of Sofosbuvir. Sofosbuvir is a NS5B inhibtor used for the treatment of hepatitis C. It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir or daclatasvir. Grades: > 95%. Molecular formula: C24H22FN3O6. Mole weight: 467.46. | |
| Sofosbuvir Impurity 7 | An impurity of Sofosbuvir. Sofosbuvir is a NS5B inhibtor used for the treatment of hepatitis C. It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir or daclatasvir. Grades: > 95%. Molecular formula: C24H21FN2O7. Mole weight: 468.44. | |
| Sofosbuvir Impurity 8 | An impurity of Sofosbuvir. Sofosbuvir is a NS5B inhibtor used for the treatment of hepatitis C. It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir or daclatasvir. Synonyms: Uridine, 2'-C-methyl-, 3',?5'-dibenzoate. Grades: > 95%. CAS No. 944476-44-2. Molecular formula: C24H22N2O8. Mole weight: 466.44. | |
| Sofosbuvir Impurity 8 | Sofosbuvir Impurity 8. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1337482-15-1. Molecular formula: C22H29FN3O9P. Mole weight: 529.46. Catalog: APB1337482151. | |
| Sofosbuvir Impurity 9 | Sofosbuvir Impurity 9. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1337482-17-3. Molecular formula: C34H45FN4O13P2. Mole weight: 798.69. Catalog: APB1337482173. | |
| Sofosbuvir impurity C | An impurity of Sofosbuvir, a medication used to treat hepatitis C. Synonyms: Sofosbuvir impurity A; (2R)-isopropyl 2- ( ( ( ( (2R, 3R, 4R, 5R)-5- (2, 4-dioxo-3, 4-dihydropyrimidin-1 (2H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy) (phenoxy)phosphoryl)amino)propanoate. CAS No. 1496552-28-3. Molecular formula: C22H29FN3O9P. Mole weight: 529.5. | |
| Sofosbuvir Impurity (GS-566500) | An impurity of Sofosbuvir. Sofosbuvir is a NS5B inhibtor used for the treatment of hepatitis C. It is only recommended with some combination of ribavirin, peginterferon-alfa, simeprevir, ledipasvir or daclatasvir. Synonyms: L-Alanine, N-[(2'R)?-2'-deoxy-2'-fluoro-2'-methyl-5'-uridylyl]?-; N-[(2'R)-2'-Deoxy-2'-fluoro-2'-methyl-5'-uridylyl]-L-alanine; PSI 352707. Grades: > 95%. CAS No. 1233335-78-8. Molecular formula: C13H19FN3O9P. Mole weight: 411.28. | |
| Sofosbuvir (PSI-7977, GS-7977) | PSI-7977 is a prodrug that is metabolized to the active antiviral agent 2'-deoxy-2'-α-fluoro- β-C-methyluridine-5'-monophosphate and is currently being investigated in phase 3 clinical trials for the treatment of hepatitis C. Studies have profiled PSI-7977 as a nucleotide inhibitor of hepatitis C virus, exerting selective inhibitory effects towards HCV NS5B polymerase. Group: Biochemicals. Alternative Names: Isopropyl (2S) -2- [ [ [ (2R, 3R, 4R, 5R) -5- (2, 4-dioxopyrimidin-1-yl) -4-fluoro-3-hydroxy-4-methyl-tetrahydrofuran-2-yl] methoxy-phenoxy-phosphoryl] amino] propanoate; N-[[P(S),2'R]-2'-deoxy-2'-fluoro-2'-methyl-P-phenyl-5'-uridylyl]-1-methylethyl Ester L-Alanine; GS-7977; PSI-7977. Grades: Highly Purified. CAS No. 1190307-88-0. Pack Sizes: 25mg, 50mg, 100mg, 250mg. Molecular Formula: C22H29FN3O9P, Molecular Weight: 529.45. US Biological Life Sciences. |  Worldwide |
| Sofosbuvir (R)-Phosphate | Sofosbuvir (R)-Phosphate. Uses: For analytical and research use. Group: Impurity standards. Catalog: APS003089. Format: Neat. | |
| 2-Defluro-2-hydroxy 2-epi-Sofosbuvir | 2-Defluro-2-hydroxy 2-epi-Sofosbuvir is an impurity of Sofosbuvir (P839640). Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 1mg, 2.5mg. Molecular Formula: C22H30N3O10P, Molecular Weight: 527.46. US Biological Life Sciences. | Worldwide |
| 2-Defluro-2-hydroxy 2-epi-Sofosbuvir-13Cd3 | 2-Defluro-2-hydroxy 2-epi-Sofosbuvir-13Cd3 is the labelled form of 2-Defluro-2-hydroxy 2-epi-Sofosbuvir (D228775), which is an impurity of Sofosbuvir (P839640). Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 1mg, 2mg. Molecular Formula: C2113CH27D3N3O10P, Molecular Weight: 531.47. US Biological Life Sciences. | Worldwide |
| 2-Defluro-2-methylene Sofosbuvir | 2-Defluro-2-methylene Sofosbuvir is an impurity of Sofosbuvir (P839640). Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 1mg, 2.5mg. Molecular Formula: C22H28N3O9P, Molecular Weight: 509.45. US Biological Life Sciences. | Worldwide |
| 2'-epi-Sofosbuvir Desphosphate | 2'-epi-Sofosbuvir Desphosphate is a possible metabolite of Sofosbuvir which is a prodrug that is metabolized to the active antiviral agent 2'-deoxy-2'-α-fluoro-β-C-methyluridine-5'-monophosphate and is currently being investigated in phase 3 clinical trials for the treatment of hepatitis C. Molecular formula: C10H13FN2O5. Mole weight: 260.22. | |
| 2-epi-Sofosbuvir Desphosphate | 2-epi-Sofosbuvir Desphosphate is possible metabolite of Sofosbuvir (P839640) which is a prodrug that is metabolized to the active antiviral agent 2'-deoxy-2'-α-fluoro- β-C-methyluridine-5'-monophosphate and is currently being investigated in phase 3 clinical trials for the treatment of hepatitis C. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 1mg. Molecular Formula: C10H13FN2O5, Molecular Weight: 260.22. US Biological Life Sciences. | Worldwide |
| 3'-O-Benzyl Sofosbuvir Desphosphate | 3'-O-Benzyl Sofosbuvir Desphosphate may be a metabolite of Sofosbuvir, a prodrug that is metabolized to the active antiviral agent 2'-deoxy-2'-α-fluoro-β-C-methyluridine-5'-monophosphate and is currently being investigated in phase 3 clinical trials for the treatment of hepatitis C. Studies have profiled PSI-7977 as a nucleotide inhibitor of hepatitis C virus, exerting selective inhibitory effects towards HCV NS5B polymerase. Synonyms: 1-((2R,3R,4R,5R)-4-(Benzyloxy)-3-fluoro-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione. Molecular formula: C17H19FN2O5. Mole weight: 350.34. | |
| 5'O-Benzyl Sofosbuvir Desphosphate | 5'O-Benzyl Sofosbuvir Desphosphate is a possible metabolite of Sofosbuvir which is a prodrug that is metabolized to the active antiviral agent 2'-deoxy-2'-α-fluoro-β-C-methyluridine-5'-monophosphate and is currently being investigated in phase 3 clinical trials for the treatment of hepatitis C. Synonyms: 5'-O-Benzyl RO 2433. Molecular formula: C17H19FN2O5. Mole weight: 350.34. | |
| α-Sofosbuvir Desphosphate | As a prodrug that is metabolized to the active antiviral agent 2'-deoxy-2'-α-fluoro-β-C-methyluridine-5'-monophosphate, α-Sofosbuvir Desphosphate is a possible metabolite of Sofosbuvir is currently being investigated in phase 3 clinical trials for the treatment of hepatitis C. Molecular formula: C10H13FN2O5. Mole weight: 260.22. | |
| Chloro Sofosbuvir | Chloro Sofosbuvir is an impurity of Sofosbuvir; a prodrug that is metabolized to the active antiviral agent 2'-deoxy-2'-α-fluoro-β-C-methyluridine-5'-monophosphate and is currently being investigated in phase 3 clinical trials for the treatment of hepatitis C. Studies have profiled Sofosbuvir as a nucleotide inhibitor of hepatitis C virus, exerting selective inhibitory effects towards HCV NS5B polymerase. Synonyms: N-[[P(S),2'R]-2'-Chloro-2'-deoxy-2'-methyl-P-phenyl-5'-uridylyl]-L-alanine 1-Methylethyl Ester. Grades: ≥98% (HPLC). CAS No. 1496552-51-2. Molecular formula: C22H29ClN3O9P. Mole weight: 545.91. | |
| ent-Sofosbuvir Desphosphate | ent-Sofosbuvir Desphosphate is a possible metabolite of prodrug that is metabolized to the active antiviral agent 2'-deoxy-2'-α-fluoro-β-C-methyluridine-5'-monophosphate and is currently being investigated in phase 3 clinical trials for the treatment of hepatitis C. Molecular formula: C10H13FN2O5. Mole weight: 260.22. | |
| 1-((2R,3R,4R,5S)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione | 1-((2R,3R,4R,5S)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione, a powerful antimicrobial agent, is renowned for its efficacy in treating a range of bacterial and fungal infections, including those caused by Candida, Aspergillus, and Cryptococcus species. This pharmaceutical marvel works by clobbering the synthesis of crucial nucleic acids in microbes to sabotage their survival. Notably, its phenomenal antibacterial and antifungal activity renders it an essential tool in the battle against streptococcal and staphylococcal infections. Synonyms: Sofosbuvir impurity SA15432. Molecular formula: C10H13FN2O5. Mole weight: 260.22. | |
| 2'-Deoxy-2'-fluoro-2'-C-methyluridine 5'-triphosphate sodium salt | PSI-7409 tetrasodium is an active 5'-triphosphate metabolite of sofosbuvir (PSI-7977), inhibiting HCV NS5B polymerases, with IC50s of 1.6, 2.8, 0.7 and 2.6 μM for GT 1b_Con1, GT 2a_JFH1, GT 3a, and GT 4a NS5B polymerases, respectively. Synonyms: PSI-7409 (tetrasodium);tetrasodium; [[[(2R,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyloxolan-2-yl]methoxy-oxidophosphoryl]oxy-oxidophosphoryl] phosphate. Grades: ≥98% (HPLC). CAS No. 1621884-22-7. Molecular formula: C10H12FN2Na4O14P3. Mole weight: 588.09. | |
| (2'R)-2'-deoxy-2'-fluoro-2'-C-methyluridine | PSI-6206 is a selective HCV RNA polymerase inhibitor. It is the unphosphorylated parent compound of triphosphate analog PSI-7409, which is a potent inhibitor of the HCV NS5B RNA dependent RNA polymerase. Synonyms: RO-2433; RO 2433; RO2433; PSI6206; PSI 6206; PSI-6206; GS331007; GS-331007; GS 331007; 2'-Deoxy-2'-fluoro-2'-C-methyluridine; Sofosbuvir Metabolite GS331007; 1-((2R,3R,4R,5R)-3-Fluoro-4-hydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione. Grades: ≥95%. CAS No. 863329-66-2. Molecular formula: C10H13FN2O5. Mole weight: 260.22. | |
| (2'R)?-2'-?Deoxy-?2'-?fluoro-?2'-?methyl-uridine 5'-?Triphosphate Triethylammonium Salt | (2'R)?-2'-?Deoxy-?2'-?fluoro-?2'-?methyl-uridine 5'-?Triphosphate Tetrasodium Salt is an impurity of Sofosbuvir (P839640) which is a prodrug that is metabolized to the active antiviral agent 2'-deoxy-2'-α-fluoro- β-C-methyluridine-5'-monophosphate. Group: Biochemicals. Grades: Highly Purified. Pack Sizes: 1mg, 10mg. Molecular Formula: C28H61FN5O14P3. US Biological Life Sciences. | Worldwide |
Our database is helping our users find suppliers everyday.
